Submit rationality and desirability of Rizatriptan plus Naproxen: CDSCO Panel Tells Akum Drugs and Pharmaceutical Dr. Divya Colin16 May 2025 6:00 PM ISTNew Delhi: Noting that the firm did not present adequate justification/rationale for the proposed fixed-dose combination (FDC) of rizatriptan benzoate...
Rizatriptan Found Ineffective for Vestibular Migraine Treatment: JAMA Jacinthlyn Sylvia15 May 2025 8:45 PM ISTA new study published in the Journal of American Medical Association showed that rizatriptan did not effectively relieve vestibular migraine symptoms...
FDA Approves Symbravo for Acute Migraine Treatment Dr. Kamal Kant Kohli2 Feb 2025 8:30 PM ISTThe US Food and Drug Administration FDA has approved Symbravo, an oral combination of meloxicam and rizatriptan, for the treatment of acute migraine...
Submit justification for dose assumption and animal toxicity data: CDSCO Panel Tells Lupin on Rizatriptan nasal spray Dr. Divya Colin29 Dec 2024 6:00 PM ISTNew Delhi: Regarding the proposed bioavailability study protocol for Rizatriptan nasal spray (2.5 mg/spray, 5 mg/spray, 7.5 mg/spray), the Subject...
Medical Bulletin 20/ September/ 2024 Dr. Bhumika Maikhuri20 Sept 2024 3:00 PM ISTHere are the top medical news for the day:Clinical Trial Finds Two common surgical approaches Equally Effective for Managing Trachomatous Trichiasis...
Systematic Review Finds Triptans Outperforms Newer Expensive Migraine Drugs Dr. Bhumika Maikhuri20 Sept 2024 8:15 AM ISTSome triptans are a more effective treatment for acute migraines than newer, more expensive drugs, finds an analysis of the latest evidence published...
Triptans more effective than newer, more expensive migraine drugs: BMJ Dr. Kamal Kant Kohli19 Sept 2024 5:00 AM ISTSome triptans are a more effective treatment for acute migraines than newer, more expensive drugs, finds an analysis of the latest evidence published...
Nagpur-based ZIM Labs gets marketing authorization for Rizatriptan in Portugal, Europe Ruchika Sharma4 July 2021 9:30 AM ISTNagpur: ZIM Laboratories Limited has recently announced that Infarmed has granted marketing authorization for its innovative product, Rizatriptan...
